Profit Or Loss [Abstract]

Tchaikapharma High Quality Medicines AD - Filing #6023734

Concept	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue	—	—	—	—	—	42 431 BGN	—	—	—	40 105 BGN	—	—	—	—
Other income	—	—	—	—	—	124,000 BGN	—	—	—	283,000 BGN	—	—	—	—
Decrease (increase) in inventories of finished goods and work in progress	—	—	—	—	—	1 020 BGN	—	—	—	784,000 BGN	—	—	—	—
Raw materials and consumables used	—	—	—	—	—	15 583 BGN	—	—	—	14 320 BGN	—	—	—	—
Employee benefits expense	—	—	—	—	—	5 680 BGN	—	—	—	4 960 BGN	—	—	—	—
Depreciation and amortisation expense	—	—	—	—	—	3 877 BGN	—	—	—	4 231 BGN	—	—	—	—
Impairment loss (reversal of impairment loss) recognised in profit or loss	—	—	—	—	—	- BGN	—	—	—	50,000 BGN	—	—	—	—
Other expenses, by nature	—	—	—	—	—	776,000 BGN	—	—	—	602,000 BGN	—	—	—	—
Profit (loss) before tax	—	—	—	—	—	1 564 BGN	—	—	—	624,000 BGN	—	—	—	—
Tax expense (income)	—	—	—	—	—	168,000 BGN	—	—	—	20,000 BGN	—	—	—	—
Profit (loss)	- BGN	- BGN	- BGN	- BGN	1 396 BGN	1 396 BGN	1 396 BGN	604,000 BGN	- BGN	604,000 BGN	- BGN	604,000 BGN	- BGN	- BGN
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent	—	—	—	—	—	1 396 BGN	—	—	—	604,000 BGN	—	—	—	—
Profit (loss), attributable to non-controlling interests	—	—	—	—	—	- BGN	—	—	—	- BGN	—	—	—	—
Earnings per share [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share	—	—	—	—	—	0.0200	—	—	—	0.0070	—	—	—	—